The delisting is "subject to the approval of the shareholders of the company by way of special resolution (through postal ballot) and obtaining in-principle approval from BSE Ltd," Claris Lifesciences said in a BSE filing.
The proposed delisting is in the interest of the shareholders, it added.
Claris Lifesciences, in a BSE filing, had earlier said it had received a letter from its promoter Athanas Enterprise Pvt Ltd to consider delisting of its shares from the stock exchange.